Your browser doesn't support javascript.
loading
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.
Li, Ying Hong; Li, Xiao Xu; Hong, Jia Jun; Wang, Yun Xia; Fu, Jian Bo; Yang, Hong; Yu, Chun Yan; Li, Feng Cheng; Hu, Jie; Xue, Wei Wei; Jiang, Yu Yang; Chen, Yu Zong; Zhu, Feng.
Afiliação
  • Li YH; Lab of Innovative Drug Research and Bioinformatics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Li XX; Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences and Collaborative Innovation Center for Brain Science, Chongqing University, Chongqing, China.
  • Hong JJ; Lab of Innovative Drug Research and Bioinformatics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Wang YX; Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences and Collaborative Innovation Center for Brain Science, Chongqing University, Chongqing, China.
  • Fu JB; Lab of Innovative Drug Research and Bioinformatics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Yang H; Lab of Innovative Drug Research and Bioinformatics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Yu CY; Lab of Innovative Drug Research and Bioinformatics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Li FC; Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences and Collaborative Innovation Center for Brain Science, Chongqing University, Chongqing, China.
  • Hu J; Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences and Collaborative Innovation Center for Brain Science, Chongqing University, Chongqing, China.
  • Xue WW; Lab of Innovative Drug Research and Bioinformatics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Jiang YY; School of International Studies, Zhejiang University, Hangzhou, China.
  • Chen YZ; Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences and Collaborative Innovation Center for Brain Science, Chongqing University, Chongqing, China.
  • Zhu F; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, Guangdong, China.
Brief Bioinform ; 21(2): 649-662, 2020 03 23.
Article em En | MEDLINE | ID: mdl-30689717
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Aprovação de Drogas / Descoberta de Drogas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Brief Bioinform Assunto da revista: BIOLOGIA / INFORMATICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Aprovação de Drogas / Descoberta de Drogas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Brief Bioinform Assunto da revista: BIOLOGIA / INFORMATICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China